DAIC

APRIL 1, 2024

Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We What is Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

HCPLive

JANUARY 16, 2025

In this episode, hosts explore ADA's evolving guidelines championing broader access to CGM and AID systems for personalized diabetes care.

Diabetes 64

Diabetes Technology 64

HCPLive

MARCH 3, 2025

In this episode, hosts discuss the implications of recent changes in GLP-1 RA availability as well as diabetes technology updates.

Diabetes 72

Diabetes Technology 72

Cardiomatics

FEBRUARY 5, 2025

We are proud to share our latest study, conducted with University Hospital Basel, and published in Diabetes Care. A key focus of the research was heart rate variability (HRV)analyzed using our AI-powered ECG technology. At Cardiomatics, we are committed to advancing cardiac research with AI-driven ECG analysis. But how does it work?

Research 93

Research Hospital Diabetes Electrophysiology 93

Cardiometabolic Health Congress

JUNE 14, 2024

In the fast-evolving world of medical technology, continuous glucose monitors (CGMs) are making headlines. Recent over-the-counter (OTC) approvals for CGM systems are transforming diabetes management and lifestyle management for those without diabetes, making this an exciting time for healthcare professionals and their patients.

Technology 105

Technology Diabetes Outcomes Innovation 105

HCPLive

FEBRUARY 27, 2024

Hosts break down their favorite sessions at the upcoming 17th International Conference on Advanced Technologies and Treatments for Diabetes.

Diabetes 64

Diabetes Technology 64

HCPLive

APRIL 4, 2025

In the first of 2 episodes spotlighting the meeting, hosts break down news and updates from the Advanced Technologies and Treatments for Diabetes meeting.

Diabetes 52

Diabetes Technology 52

Cardiometabolic Health Congress

SEPTEMBER 19, 2024

Developed by Senseonics and Ascensia Diabetes Care, the device represents a significant advancement in long-term glucose monitoring technology. The approval addresses several challenges faced by diabetes patients, including the inconvenience of frequent sensor changes, accidental dislodgement, and data interruptions.

Diabetes 59

Diabetes Technology Innovation 59

Cardiometabolic Health Congress

MAY 24, 2024

Continuous Glucose Monitor (CGM) Management: Comparing is-CGM And rt-CGM While HbA1C and blood finger sticks have been standard tools in diabetes management, Continuous Glucose Monitor (CGM) provides a more comprehensive and accurate picture of glucose levels for better decision-making.

Diabetes 98

Diabetes Technology Congenital Outcomes 98

DAIC

DECEMBER 26, 2023

reported results from a clinical study of revolutionary earbuds that use a new technology - In-ear Infrasonic Hemodynography to Detects Aortic Stenosis Murmur Before and After Transcatheter Aortic Valve Replacement (TAVR). milla1cf Tue, 12/26/2023 - 21:36 December 26, 2023 — MindMics, Inc.

Stenosis 59

Stenosis Technology Aortic Aortic valve 59

DAIC

MARCH 6, 2024

The FDA’s Breakthrough Device Designation is granted for technologies that have the possibility to encourage more effective diagnosis or treatment for life-threatening or irreversibly debilitating diseases. Cleerly is committed to accelerating the availability of its technology to healthcare providers and patients alike.

Heart Disease 105

Heart Disease Heart Attack Heart attacks Technology 105

Circulation

NOVEMBER 11, 2024

Despite these technological strides, their adoption and sustained use remain limited to health-conscious individuals. The general populace, particularly those indifferent to health management, stands to miss out on the potential benefits of wearable technologies due to a lack of engagement. for 30-second data segments and 80.9%

Hypertension 45

Hypertension Diabetes Blood Pressure Technology 45

DAIC

MARCH 1, 2024

Following Breakthrough Device Designation granted for the technology by the FDA in 2021, the approval was supported by positive results from the multicenter, prospective, randomized controlled AGENT IDE trial , which enrolled 600 patients at 40 U.S. Boston Scientific plans to launch the technology in the U.S. vs. 28.7%; P=0.006).

Stent 105

Stent Stents Coronary Artery Disease Angioplasty 105

HCPLive

MARCH 30, 2024

In this episode, hosts discuss GLP-1 RA use and CGM technology, updates in once-weekly insulins, the concept of continuous ketone monitoring, and practical application of artificial intelligence into care.

Diabetes 59

Diabetes Technology 59

MIBHS

FEBRUARY 28, 2025

Maintain a Healthy Weight: Obesity amplifies the effects of genetic predispositions by contributing to high cholesterol, hypertension, and diabetes. Gene-based therapies and interventions, such as gene editing technologies, show potential in treating hereditary conditions, although these treatments are still in early stages.

Genetic predisposition 52

Genetic predisposition Heart Disease Cholesterol Blood Pressure 52

DAIC

MARCH 10, 2025

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Digital technologies may reveal it is even more common than the current analysis indicates. Earlier projections had estimated that 3.3

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

Cardiometabolic Health Congress

JULY 25, 2024

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

Education 100

Education Innovation Risk Factors Obesity 100

DAIC

MARCH 13, 2024

In an original investigation presented at the Cardiology Research Technology conference in Washington, D.C. Even with advances in stent technology, patients with coronary in-stent restenosis continue to comprise approximately 10 percent of individuals undergoing angioplasty interventions each year. and Susan F.

Angioplasty 116

Angioplasty Stent Stents Myocardial Infarction 116

Cardiometabolic Health Congress

AUGUST 2, 2024

The Omics Revolution: Powering Precision Nutrition Omics technologies form the backbone of genetically tailored nutrition, providing unprecedented insights into the molecular intricacies of human biology: Genomics : Unraveling the DNA blueprint to identify genetic variations that influence nutrient metabolism and dietary responses.

Diet 59

Diet Technology Coronary Artery Disease Quality of Life 59

Cardiometabolic Health Congress

OCTOBER 10, 2024

Vitadio : Digital therapeutics for type 2 diabetes and prediabetes, expanding globally. LumineticsCore : An AI diagnostics company with FDA-cleared systems for detecting diabetic retinopathy. Acorai : A heart failure monitoring platform using AI to track and predict patient health.

Innovation 52

Innovation Technology Kidney Disease Chronic Disease 52

American College of Cardiology

OCTOBER 27, 2024

New science presented at TCT 2024 and simultaneously published across the family of JACC Journals sheds light on topics including photon-counting detector-computed tomography (PCD-CT), new and emerging technologies for treating patients with cardiovascular diseases, fractional flow reserve (FFR) and resting full-cycle ratio for predicting myocardial (..)

Ultrasound 40

Ultrasound Ischemia Technology Cardiovascular Disease 40

DAIC

JULY 1, 2024

Diabetes Care, Mardil Medical, and Catheter Robotics. Englund brings over 25 years of experience in the medical device industry, most recently serving as Senior Vice President, Scientific Affairs at Monteris Medical, where she established a strong clinical portfolio that was pivotal in achieving reimbursement and clinical guideline status.

Reimbursement 105

Reimbursement RN Heart Failure Laboratory 105

DAIC

FEBRUARY 29, 2024

12:15 p.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

First-generation polymer-free stent technologies, such as sirolimus- and probucol-eluting stents (PF-SES), have shown an excellent safety and efficacy profile. years, Diabetes mellitus 29%, acute coronary syndrome 67%, chronic total occlusion 9%). The primary endpoint was target-lesion revascularization (TLR) at 1 year.

Stent 64

Stent Stents Cardiogenic Shock Coronary Artery Disease 64

DAIC

MAY 8, 2024

At the Feinstein Institutes, medical researchers use modern technology to develop new device-based therapies to treat disease and injury. The Feinstein Institutes for Medical Research is the global scientific home of bioelectronic medicine , which combines molecular medicine, neuroscience, and biomedical engineering.

Ultrasound 115

Ultrasound Pulmonary Research Hypertension 115

DAIC

MAY 7, 2024

WMHs are related to chronic hypertension, diabetes, high cholesterol, and smoking, among other factors and conditions, and have been strongly related to cognitive impairment, but not extensively studied in the context of motor impairment. difficulty moving or using their arm for daily tasks), independent of CST damage. Toga, PhD. "We

Stroke 105

Stroke Strokes Research Public Health 105

CardiacWire

APRIL 10, 2024

GLP-1s Are So Hot Right Now – In the year since ACC 2023, GLP-1s went from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming a promising (and Medicare-covered) option for CV event reduction.

Innovation 59

Innovation Technology Interventional Cardiology Medicare 59

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

GEMMS

MAY 22, 2024

Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. Startups are developing image analytics solutions using deep learning technologies to improve patient outcomes.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

GEMMS

JUNE 25, 2024

Pregnancy-related complications, such as preeclampsia and gestational diabetes, also elevate the chances of developing heart disease later in life. Additionally, conditions like diabetes can significantly increase the likelihood of heart disease in women, who may also experience silent heart attacks due to altered pain perception.

Heart Disease 52

Heart Disease Risk Factors Diet Chest Pain 52

DAIC

MARCH 5, 2024

FIRE1 seeks to transform heart failure management by enabling patients to monitor and control their fluid volume themselves with a consumer-friendly device at home, similar to how continuous glucose monitoring transformed diabetes care. and is the most common cause of hospitalization for those aged 65 and over.

Heart Failure 52

Heart Failure Innovation Hospital Technology 52

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Digital technologies may reveal it is even more common than the current analysis indicates. Earlier projections had estimated that 3.3

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Cardiometabolic Health Congress

NOVEMBER 16, 2023

Recent technological advances, pathophysiology, and pharmacotherapy have contributed to a near-universal recognition of the overlap between ​cardiovascular, ​kidney, and ​metabolic diseases. Measuring both albuminuria and eGFR improves renal risk stratification in diabetes and chronic kidney disease.

Kidney Disease 52

Kidney Disease Blood Pressure Diabetes Hospital 52

DAIC

DECEMBER 19, 2023

This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

Circulation

NOVEMBER 11, 2024

This score ranges from 0-10; the lower its numerical value, the greater the microvascular impairment.Results:Twenty patients were included (61±10 years old, 85% males, 55% anterior AMI, 70% hypertension, 25% diabetes, 45% current smoker, all underwent primary PCI). The time between the two sublingual assessments was 188±31 days. The PBR [1.96±0.22µm

Myocardial Infarction 40

Myocardial Infarction Plaque Technology Diabetes 40

Cardiometabolic Health Congress

AUGUST 2, 2023

Dr. Caballero is an endocrinologist, clinical investigator, and faculty director of International Innovation and Diabetes Education at Harvard Medical School. These conditions affect a patient’s risk of health conditions like heart disease, diabetes, and obesity. ” “But,” cautions Dr. .”

Education 40

Education Health Disparities Webinar Diabetes 40